1493

Free-breathing 3D cardiac extracellular volume (ECV) mapping using a linear tangent space alignment (LTSA) model
Wonil Lee1,2, Paul Kyu Han1,2, Thibault Marin1,2, Ismael Brahim Georges Mounime1,2,3, Samira Vafay Eslahi1,2, Yanis Djebra1,2, Didi Chi1,2, Georges El Fakhri4, and Chao Ma1,2
1Department of Radiology, Massachusetts General Hospital, Boston, MA, United States, 2Department of Radiology, Harvard Medical School, Boston, MA, United States, 3LTCI, Telecom Paris, Institut Polytechnique de Paris, Paris, France, 4Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, United States

Synopsis

Keywords: Myocardium, Cardiovascular, Extracellular volume fraction (ECV)

Motivation: Extracellular volume (ECV) is an emerging biomarker for diffuse fibrosis, which is known to be particularly challenging to detect. Existing methods are limited to single-slice acquisition with or without breath-hold.

Goal(s): To develop a new method for free-breathing, 3D ECV mapping of the whole heart.

Approach: 3D cardiac T1 mapping was performed before and after contrast agent injection using a free-breathing, ECG-gated IR-FLASH sequence followed by a linear tangent space alignment model-based image reconstruction.

Results: The estimated ECV values from the proposed method were comparable to those from the reference MOLLI method.

Impact: The proposed method allows for free-breathing, 3D ECV mapping of the whole heart in a practically feasible imaging time. The proposed method is potentially useful ECV quantitation in healthy and diseased populations with diffuse fibrosis.

Introduction

Cardiac $$$T_1$$$ mapping is a powerful MRI technique for identifying the tissue structure and underlying pathological causes of the myocardium. Extracellular volume (ECV) fraction, a quantitative metric that can be derived from pre- and post-contrast $$$T_1$$$values, is an emerging biomarker for amyloidosis1, myocardial injury2, and particularly diffuse fibrosis3, 4, which is known to be challenging to detect using the conventional late gadolinium enhancement (LGE) method. Cardiac ECV mapping is challenging due to respiratory and cardiac motions. Also, $$$T_1$$$ values change over time after the administration of contrast agent injection, which makes it difficult to estimate the post-contrast $$$T_1$$$ accurately for the relatively long 3D acquisition. As a result, the existing methods are limited to 2D ECV mapping, which often suffers from limited spatial coverage and/or through-plane resolution5. In this work, we propose a new method to enable free-breathing, 3D ECV mapping of the whole heart.

Method

Data acquisition
All experiments were performed under a study protocol approved by our local institutional review board (IRB). Four healthy volunteers (1M and 3F; 43 ± 16 years) were imaged using a 3T PET/MR scanner (Biograph mMR, Siemens Healthcare, Erlangen, Germany). Imaging was performed using a free-breathing, ECG-gated, inversion recovery (IR) sequence with sparse-sampling (Fig.1) 6, before and after the contrast-agent injection (Dotarem®, 0.1 mmol/kg). Data was acquired using a 3D spoiled gradient-echo (SPGR) readout with the following imaging parameters: field-of-view (FOV) = 308×308×144 mm3, spatial resolution = 1.9×1.9×4.5 mm3, flip angle (FA) = 9°, TR = 4.2 ms, TE = 1.7 ms, 10-(3)-10-(3) protocol, acquisition window per frame = 138.6 ms, and total number of frames = 900 (which corresponds to acquisition times of 12.4 ± 1.4 and 11.0 ± 0.7 min for pre- and post-contrast injection acquisitions, respectively).
Reconstruction
Dynamic MR images were reconstructed using the Linear Tangent Subspace Alignment (LTSA) model7,8, which exploits the low-dimensional manifold structure of dynamic MR images in order to reduce the dimensionality of the image reconstruction problem. The LTSA model expresses dynamic MR images $$$X \in \mathbb{C}^{M\times N}$$$ where $$$M$$$ is the number of pixels and $$$N$$$ the number of time frames, split into $$$C$$$ neighborhoods $$$X_c$$$, $$$c=1,\dots,C$$$ as: $$$X_c = \boldsymbol{T} \boldsymbol{L}_c \boldsymbol{\Phi}_c^\top$$$, where $$$\boldsymbol{T}$$$ represents the global coordinates of the manifold, $$$\boldsymbol{L}_c$$$ is a linear alignment transform from local to global coordinates and $$$\boldsymbol{\Phi}_c$$$ is a set of temporal bases estimated from the acquired training lines via SVD. Neighborhoods were selected to match respiratory phases, which were estimated using a navigator acquired near the liver/lung interface. The resulting reconstruction problem was: $$\arg\min_{T,L} \left\|\boldsymbol{\Omega}\left( \boldsymbol{F}_s \sum_c \boldsymbol{T} \boldsymbol{L_c} \boldsymbol{\Phi_c} \boldsymbol{\Pi_c}\right) - \boldsymbol{s} \right\|_2^2 + \frac{\mu_L}{2} \left\|\boldsymbol{L}\right\|_F^2 + \frac{\mu_T}{2} \left\|\boldsymbol{T}\right\|_F^2 + \lambda_T \left\|\mathcal{D}\boldsymbol{T}\right\|_1 + \lambda_L \left\|\boldsymbol{L}\right\|_1,$$ where $$$\boldsymbol{\Omega}$$$ is the sparse sampling operator, $$$\boldsymbol{F}_s$$$ is the nonuniform Fourier transform operator implemented via NUFFT9, $$$\boldsymbol{\Pi_c}$$$ is a frame selection operator, $$$\boldsymbol{s}$$$ is the acquired k-space data, $$$\mu_L$$$ and $$$\mu_T$$$ are scalar weights controlling the $$$\ell_2$$$ regularization strength on $$$\boldsymbol{T}$$$ and $$$\boldsymbol{L}$$$ respectively, $$$\left\|.\right\|_F$$$ is the Frobenius norm, $$$\mathcal{D}$$$ is the finite difference operator and $$$\lambda_T$$$ and $$$\lambda_L$$$ are scalar weights controlling the strength of the total variation on $$$\boldsymbol{T}$$$ and sparsity penalty on $$$\boldsymbol{L}$$$ respectively. The alternating direction method of multipliers10 was used to solve this optimization problem.
T1 mapping
Joint $$$T_1$$$ and transmit $$$B_1$$$ ($$$B_1^+$$$) mapping was performed as in 6, using a grid search over a dictionary of basis functions generated following Bloch equations for a range of $$$T_1$$$ and effective $$$B_1^+$$$ values. For each pixel and each respiratory bin, a grid search was performed over the parameters, following the variable projection method. For mapping of the post-contrast images, basis functions were generated assuming a linear $$$T_1$$$ change over time, thus adding a third parameter, the $$$T_1$$$ rate of change, to the grid search. We compared the proposed method with Modified Look-Locker Inversion Recovery (MOLLI).

Results

Figures 2 to 4 show the results of pre-contrast $$$T_1$$$, post-contrast $$$T_1$$$, and ECV maps, respectively. 3D pre-contrast $$$T_1$$$, post-contrast $$$T_1$$$, and ECV maps were successfully generated for the whole heart using the proposed method. Qualitatively, the estimated pre-contrast $$$T_1$$$, post-contrast $$$T_1$$$, and ECV were comparable to those acquired from MOLLI. Figure 5 shows the group results of Bull’s eye plots for pre-contrast T1 and ECV. Results show that the estimated pre-contrast $$$T_1$$$ and ECV were comparable to those acquired from MOLLI quantitatively (Fig. 5).

Conclusion

The proposed method allowed free-breathing, 3D ECV mapping in a practically feasible imaging time. The estimated ECV values from the proposed method were comparable to those from the existing method.

Acknowledgements

This work was supported in part by the National Institutes of Health (K01EB030045, P41EB022544, R01CA165221, R01EB033582, R01HL137230, and T32EB013180).

References

1. Karamitsos TD, Piechnik SK, Banypersad SM, et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC: Cardiovascular Imaging. 2013;6(4):488-497.

2. Ferreira VM, Piechnik SK, Dall'Armellina E, et al. T1 mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC: Cardiovascular Imaging. 2013;6(10):1048-1058.

3. Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. Journal of the American College of Cardiology. 2011;57(8):891-903.

4. Liu S, Han J, Nacif MS, et al. Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials. Journal of Cardiovascular Magnetic Resonance. 2012;14:1-8.

5. Robinson AA, Chow K, Salerno M. Myocardial T1 and ECV measurement: underlying concepts and technical considerations. JACC: Cardiovascular Imaging. 2019;12(11 Part 2):2332-2344.

6. Han PK, Marin T, Djebra Y, et al. Free‐breathing 3D cardiac T1 mapping with transmit B1 correction at 3T. Magnetic Resonance in Medicine. 2022;87(4):1832-1845.

7. Ma C, Han PK, Zhuo Y, Djebra Y, Marin T, Fakhri GE. Joint spectral quantification of MR spectroscopic imaging using linear tangent space alignment‐based manifold learning. Magnetic resonance in medicine. 2023;89(4):1297-1313.

8. Djebra Y, Marin T, Han PK, Bloch I, El Fakhri G, Ma C. Manifold learning via linear tangent space alignment (LTSA) for accelerated dynamic MRI with sparse sampling. IEEE Transactions on Medical Imaging. 2022;42(1):158-169.

9. Fessler JA, Sutton BP. Nonuniform fast Fourier transforms using min-max interpolation. IEEE transactions on signal processing. 2003;51(2):560-574.

10. Boyd S, Parikh N, Chu E, Peleato B, Eckstein J. Distributed optimization and statistical learning via the alternating direction method of multipliers. Foundations and Trends® in Machine learning. 2011;3(1):1-122.

Figures

Figure 1. Schematic diagrams for 3D ECV mapping of the heart. a) Schematic diagram of the experimental timeline. Cardiac T1 mapping is performed both before and after the injection of Gadolinium. b) Illustration of training data acquisition. Pulse sequence diagram for acquisition of three lines in the $$$k_x$$$, $$$k_y$$$, and $$$k_z$$$ directions is shown. c) Illustration of imaging data acquisition. Pulse sequence diagram for acquisition with a randomized order of $$$k_z$$$ and radial spokes over time is shown.

Figure 2. Results of pre-contrast T1 maps. (a) 3D pre-contrast T1 maps from the proposed method. (b) Comparison between the proposed method and MOLLI. The corresponding basal, mid, and apical slices are denoted by red, blue, and green boxes, respectively.

Figure 3. Results of post-contrast T1 maps. (a) 3D post-contrast T1 maps from the proposed method. (b) Comparison between the proposed method and MOLLI. The corresponding basal, mid, and apical slices are denoted by red, blue, and green boxes, respectively.

Figure 4. Results of ECV maps. (a) 3D ECV maps from the proposed method. (b) Comparison between the proposed method and MOLLI. The basal, mid, and apical slices are denoted by the red, black, and green boxes, respectively.

Figure 5. Group results of Bull’s eye plot. Bull’s eye plots of average pre-contrast T1 (a-b), schematic diagram of the experimental timeline (c), and Bull’s eye plots of average ECV (d-g) are shown. Note that group analyses could not be performed for the case of post-contrast T1 due to the variability in acquisition time after injection among subjects.

Proc. Intl. Soc. Mag. Reson. Med. 32 (2024)
1493
DOI: https://doi.org/10.58530/2024/1493